Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
2.04
Dollar change
-0.03
Percentage change
-1.45
%
Index- P/E- EPS (ttm)-0.06 Insider Own11.96% Shs Outstand32.32M Perf Week-4.23%
Market Cap64.97M Forward P/E- EPS next Y-0.09 Insider Trans-0.85% Shs Float28.45M Perf Month-22.43%
Income-1.53M PEG- EPS next Q0.00 Inst Own29.27% Short Float3.46% Perf Quarter-47.01%
Sales98.92M P/S0.66 EPS this Y102.78% Inst Trans118.30% Short Ratio1.31 Perf Half Y10.27%
Book/sh0.90 P/B2.26 EPS next Y-1000.00% ROA-2.78% Short Interest0.99M Perf Year17.24%
Cash/sh0.57 P/C3.56 EPS next 5Y38.00% ROE-6.03% 52W Range1.16 - 5.15 Perf YTD7.94%
Dividend Est.- P/FCF24.71 EPS past 5Y44.20% ROI-3.75% 52W High-60.39% Beta1.38
Dividend TTM- Quick Ratio2.00 Sales past 5Y6.03% Gross Margin16.91% 52W Low75.86% ATR (14)0.18
Dividend Ex-Date- Current Ratio2.41 EPS Y/Y TTM89.55% Oper. Margin0.59% RSI (14)31.00 Volatility4.32% 6.14%
Employees237 Debt/Eq0.49 Sales Y/Y TTM22.37% Profit Margin-1.54% Recom1.00 Target Price6.00
Option/ShortYes / Yes LT Debt/Eq0.40 EPS Q/Q164.85% Payout- Rel Volume0.58 Prev Close2.07
Sales Surprise6.82% EPS Surprise400.00% Sales Q/Q19.12% EarningsNov 12 BMO Avg Volume754.59K Price2.04
SMA20-8.10% SMA50-33.20% SMA200-13.72% Trades Volume437,315 Change-1.45%
Date Action Analyst Rating Change Price Target Change
Nov-14-24Initiated Rodman & Renshaw Buy $5
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Dec-13-24 03:48PM
12:11PM
Dec-12-24 06:00AM
Dec-05-24 06:00AM
Nov-19-24 06:00AM
02:06AM Loading…
Nov-13-24 02:06AM
Nov-12-24 10:01PM
07:10AM
06:12AM
06:00AM
Nov-11-24 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
Oct-14-24 06:00AM
05:33PM Loading…
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
Aug-08-24 07:15AM
06:13AM
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
06:00AM Loading…
Jul-11-24 06:00AM
May-30-24 06:00AM
May-15-24 08:19AM
03:01AM
12:37AM
May-14-24 10:54AM
07:15AM
06:11AM
06:00AM
Apr-17-24 06:00AM
Apr-16-24 06:00AM
Apr-04-24 06:00AM
Mar-26-24 06:15PM
Mar-25-24 06:00AM
Mar-22-24 09:52AM
Mar-21-24 09:39PM
10:53AM
07:10AM
06:18AM
06:00AM
Mar-11-24 06:15PM
Mar-05-24 06:00PM
Feb-27-24 06:00PM
Feb-20-24 06:00PM
Feb-14-24 06:00PM
Feb-08-24 06:00AM
Jan-08-24 07:30AM
Nov-15-23 01:29PM
Nov-14-23 10:36PM
07:15AM
06:06AM
06:00AM
Nov-07-23 06:00PM
Oct-26-23 06:00PM
Oct-20-23 06:15PM
Oct-18-23 06:00AM
Oct-17-23 06:00AM
Oct-16-23 06:00AM
Oct-13-23 06:15PM
Oct-03-23 06:15PM
06:00AM
Sep-28-23 06:00AM
Sep-27-23 06:15PM
Sep-21-23 06:15PM
06:30AM
Sep-18-23 11:37AM
Sep-07-23 06:00AM
Aug-15-23 12:29PM
Aug-14-23 10:53PM
06:08AM
06:00AM
Aug-11-23 10:28AM
Aug-10-23 10:00AM
Aug-09-23 06:00AM
Aug-01-23 06:25PM
Jul-26-23 06:00PM
Jul-21-23 06:15PM
Jul-17-23 06:00AM
Jul-12-23 10:00AM
06:10AM
Jul-11-23 06:00AM
Jul-03-23 09:35AM
08:50AM
Jun-29-23 06:00AM
Jun-28-23 09:26AM
Jun-27-23 12:00PM
Jun-26-23 06:00AM
Jun-23-23 07:43AM
Jun-20-23 06:09AM
Jun-19-23 08:50AM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RAVICH MARK HDirectorNov 15 '24Sale2.3219,99146,3790Nov 19 04:21 PM
RAVICH MARK HDirectorNov 15 '24Sale2.4010,00024,000121,429Nov 19 04:21 PM
Chole TimothySVP, Chief Commercial OfficerOct 01 '24Sale3.691,0013,68955,171Oct 02 09:55 PM
Strobeck MarkPresident and CEOOct 01 '24Sale3.692,1637,971147,201Oct 02 09:54 PM
Strobeck MarkOfficerOct 01 '24Proposed Sale3.652,1637,900Oct 01 02:05 PM
Chole TimothyOfficerOct 01 '24Proposed Sale3.601,0013,600Oct 01 01:36 PM